Literature DB >> 15236849

Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection.

C Defez1, P Fabbro-Peray, N Bouziges, A Gouby, A Mahamat, J P Daurès, A Sotto.   

Abstract

A case-control study was conducted in a university hospital to determine the risk factors for nosocomial infection with multidrug-resistant Pseudomonas aeruginosa (MDR-PA) among all hospitalized patients and among those with a nosocomial infection due to P. aeruginosa. Eighty patients infected with MDR-PA, 75 infected with a non-MDR phenotype and 240 random controls were included in the 12-month study. Among all hospitalized patients, age, severity index, having a bedridden condition, transfer from other units, nasogastric feeding, urinary catheterization and exposure to beta-lactams (OR=2.5) or fluoroquinolones (OR=4.1) in the seven days before infection were linked to nosocomial infection due to MDR-PA. Among patients infected by P. aeruginosa, exposure to fluoroquinolones (OR=4.7) or surgery (OR=0.5) were linked to the isolation of MDR-PA. This study showed that, in addition to urinary catheterization, nasogastric feeding is an important risk factor in MDR-PA infection. Indeed, an imbalance in gut flora, modifications to the mucous membranes due to the use of nasogastric feeding and the selection pressures exerted by antibiotics were implicated in the occurrence of this infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15236849     DOI: 10.1016/j.jhin.2004.03.022

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  33 in total

1.  Role of hospital stay and antibiotic use on Pseudomonas aeruginosa gastrointestinal colonization in hospitalized patients.

Authors:  D Lepelletier; N Caroff; D Riochet; P Bizouarn; A Bourdeau; F Le Gallou; E Espaze; A Reynaud; H Richet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-09       Impact factor: 3.267

Review 2.  Clinical and economic impact of common multidrug-resistant gram-negative bacilli.

Authors:  Christian G Giske; Dominique L Monnet; Otto Cars; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

3.  Susceptibility of Pseudomonas aeruginosa urinary tract isolates and influence of urinary tract conditions on antibiotic tolerance.

Authors:  Maike Narten; Nathalie Rosin; Max Schobert; Petra Tielen
Journal:  Curr Microbiol       Date:  2011-10-08       Impact factor: 2.188

4.  Antibiotic pressure is a major risk factor for rectal colonization by multidrug-resistant Pseudomonas aeruginosa in critically ill patients.

Authors:  Silvia Gómez-Zorrilla; Mariana Camoez; Fe Tubau; Elisabet Periche; Rosario Cañizares; M Angeles Dominguez; Javier Ariza; Carmen Peña
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

5.  Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients.

Authors:  C Peña; S Gómez-Zorrilla; C Suarez; M A Dominguez; F Tubau; O Arch; A Oliver; M Pujol; J Ariza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-04       Impact factor: 3.267

6.  Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia.

Authors:  Alain Combes; Charles-Edouard Luyt; Jean-Yves Fagon; Michel Wolff; Jean-Louis Trouillet; Jean Chastre
Journal:  Intensive Care Med       Date:  2006-09-07       Impact factor: 17.440

7.  Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.

Authors:  Simone Aranha Nouér; Marcio Nucci; Márcia P de-Oliveira; Flávia Lúcia Piffano Costa Pellegrino; Beatriz Meurer Moreira
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

Review 8.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

9.  Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients.

Authors:  José A Martínez; Esther Delgado; Sara Martí; Francesc Marco; Jordi Vila; Josep Mensa; Antoni Torres; Carles Codina; Antoni Trilla; Alex Soriano; Aitor Alquezar; Pedro Castro; José M Nicolás
Journal:  Intensive Care Med       Date:  2008-10-21       Impact factor: 17.440

10.  Bacterial and clinical characteristics of health care- and community-acquired bloodstream infections due to Pseudomonas aeruginosa.

Authors:  Angela Hattemer; Alan Hauser; Maureen Diaz; Marc Scheetz; Nirav Shah; Jonathan P Allen; Jahan Porhomayon; Ali A El-Solh
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.